CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,199,950 | -9.7% | 2,654,445 | 0.0% | 0.58% | +32.7% |
| Q2 2023 | $86,587,996 | -5.8% | 2,654,445 | +1.6% | 0.44% | -26.8% |
| Q1 2023 | $91,905,441 | -26.4% | 2,611,692 | -4.2% | 0.60% | -40.0% |
| Q4 2022 | $124,849,282 | -3.5% | 2,724,777 | +2.0% | 1.00% | +20.6% |
| Q3 2022 | $129,441,000 | +8.8% | 2,671,648 | -11.7% | 0.82% | +18.2% |
| Q2 2022 | $118,917,000 | +1.5% | 3,026,648 | -4.9% | 0.70% | +32.2% |
| Q1 2022 | $117,104,000 | -30.0% | 3,181,300 | -13.4% | 0.53% | -15.9% |
| Q4 2021 | $167,368,000 | +55.3% | 3,671,969 | +21.8% | 0.63% | +42.7% |
| Q3 2021 | $107,752,000 | +124.1% | 3,014,882 | +24.1% | 0.44% | +110.5% |
| Q2 2021 | $48,072,000 | -22.6% | 2,429,100 | -9.1% | 0.21% | -45.7% |
| Q1 2021 | $62,148,000 | -8.6% | 2,671,884 | -18.3% | 0.38% | -6.6% |
| Q4 2020 | $67,990,000 | – | 3,271,884 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |